This document summarizes changes from the proposed rule to the final rule for Stage 1 of the Medicare and Medicaid EHR Incentive Program's meaningful use criteria. Key changes included lowering thresholds for some objectives, removing administrative transactions, adding new objectives, and modifying clinical quality measures for eligible professionals. The final rule provided more flexibility for states and clarified various eligibility and reporting requirements.
Eligible professionals and hospitals have core and menu objectives they must meet to achieve Stage 1 Meaningful Use of electronic health records. Objectives include items like electronic prescribing, clinical decision support, and exchanging key clinical information. Professionals must complete 20 objectives total and hospitals must complete 19. Both must report on clinical quality measures to CMS or states. The document provides details on Stage 1 Meaningful Use requirements and measures.
This document provides an overview of the requirements for achieving Meaningful Use under the Medicare and Medicaid EHR Incentive Programs. It defines Meaningful Use as using certified EHR technology to improve quality, safety, efficiency and health outcomes. The three main components of Meaningful Use are use of EHRs in a meaningful manner, electronic exchange of health information, and submission of clinical quality measures. Stage 1 requirements include completing core and menu set objectives related to EHR usage, engaging patients, care coordination, and privacy/security. Eligible professionals must meet 15 core objectives and hospitals must meet 14.
Slides presented at the July 13, 2010 press conference announcing the final rules for Meaningful Use. These rules define what qualifies for stimulus incentive payments under the ARRA/HITECH legislation.
The document discusses the objectives and requirements of Meaningful Use (MU), an incentive program that promotes the adoption and meaningful use of electronic health records (EHRs). It outlines the core objectives that eligible professionals and hospitals must meet, such as computerized provider order entry, maintaining active medication lists, and exchanging key clinical information. The document also details the measure thresholds associated with each objective that providers must meet to qualify for MU incentive payments.
This document provides an overview and summary of changes between the proposed rule and final rule for implementing the Medicare and Medicaid EHR Incentive Program under the HITECH Act. Some key changes included modifications to the meaningful use criteria and clinical quality measures, clarification of provider eligibility requirements, and adjustment of measure thresholds. The final rule aimed to address concerns raised in public comments to better achieve the goals of improved care, health outcomes, and interoperability.
The document discusses changes between the proposed rule and final rule for implementing the Medicare and Medicaid EHR Incentive Program under the HITECH Act. Key changes included lowering the thresholds for meaningful use measures, modifying clinical quality measures, and clarifying eligible provider and hospital definitions. The final rule aimed to ease burden and address concerns raised during public comment period.
The document summarizes a proposed rule from the Centers for Medicare & Medicaid Services (CMS) to implement incentive programs for hospitals and healthcare providers to adopt electronic health records (EHRs) as authorized by the Health Information Technology for Economic and Clinical Health (HITECH) Act. The proposed rule defines meaningful use criteria for EHRs, outlines incentive payment structures and eligibility over multiple stages and years, and solicits public comments on the proposals by March 15, 2010.
The document summarizes changes to the Meaningful Use Stage 2 rules for electronic health record incentive programs. Key changes include allowing a 90-day reporting period in 2017 for first-time participants and those choosing to implement Stage 3 in 2017. It modifies measures related to patient engagement, public health reporting, and thresholds for Stage 3 objectives like computerized provider order entry and electronic prescribing. The final rule also changes the 2015 reporting period to 90 days and aligns future periods with the calendar year. It streamlines programs by removing redundant measures and modifies several objectives and measures for Stages 1, 2 and 3.
Eligible professionals and hospitals have core and menu objectives they must meet to achieve Stage 1 Meaningful Use of electronic health records. Objectives include items like electronic prescribing, clinical decision support, and exchanging key clinical information. Professionals must complete 20 objectives total and hospitals must complete 19. Both must report on clinical quality measures to CMS or states. The document provides details on Stage 1 Meaningful Use requirements and measures.
This document provides an overview of the requirements for achieving Meaningful Use under the Medicare and Medicaid EHR Incentive Programs. It defines Meaningful Use as using certified EHR technology to improve quality, safety, efficiency and health outcomes. The three main components of Meaningful Use are use of EHRs in a meaningful manner, electronic exchange of health information, and submission of clinical quality measures. Stage 1 requirements include completing core and menu set objectives related to EHR usage, engaging patients, care coordination, and privacy/security. Eligible professionals must meet 15 core objectives and hospitals must meet 14.
Slides presented at the July 13, 2010 press conference announcing the final rules for Meaningful Use. These rules define what qualifies for stimulus incentive payments under the ARRA/HITECH legislation.
The document discusses the objectives and requirements of Meaningful Use (MU), an incentive program that promotes the adoption and meaningful use of electronic health records (EHRs). It outlines the core objectives that eligible professionals and hospitals must meet, such as computerized provider order entry, maintaining active medication lists, and exchanging key clinical information. The document also details the measure thresholds associated with each objective that providers must meet to qualify for MU incentive payments.
This document provides an overview and summary of changes between the proposed rule and final rule for implementing the Medicare and Medicaid EHR Incentive Program under the HITECH Act. Some key changes included modifications to the meaningful use criteria and clinical quality measures, clarification of provider eligibility requirements, and adjustment of measure thresholds. The final rule aimed to address concerns raised in public comments to better achieve the goals of improved care, health outcomes, and interoperability.
The document discusses changes between the proposed rule and final rule for implementing the Medicare and Medicaid EHR Incentive Program under the HITECH Act. Key changes included lowering the thresholds for meaningful use measures, modifying clinical quality measures, and clarifying eligible provider and hospital definitions. The final rule aimed to ease burden and address concerns raised during public comment period.
The document summarizes a proposed rule from the Centers for Medicare & Medicaid Services (CMS) to implement incentive programs for hospitals and healthcare providers to adopt electronic health records (EHRs) as authorized by the Health Information Technology for Economic and Clinical Health (HITECH) Act. The proposed rule defines meaningful use criteria for EHRs, outlines incentive payment structures and eligibility over multiple stages and years, and solicits public comments on the proposals by March 15, 2010.
The document summarizes changes to the Meaningful Use Stage 2 rules for electronic health record incentive programs. Key changes include allowing a 90-day reporting period in 2017 for first-time participants and those choosing to implement Stage 3 in 2017. It modifies measures related to patient engagement, public health reporting, and thresholds for Stage 3 objectives like computerized provider order entry and electronic prescribing. The final rule also changes the 2015 reporting period to 90 days and aligns future periods with the calendar year. It streamlines programs by removing redundant measures and modifies several objectives and measures for Stages 1, 2 and 3.
- The document discusses the requirements and incentives for physicians to achieve Meaningful Use of electronic health records as part of the government's stimulus program.
- Physicians must meet objectives in three stages involving electronic prescribing, clinical quality reporting, and advanced clinical processes to receive incentive payments of up to $44,000 from Medicare or $63,750 from Medi-Cal.
- Achieving Meaningful Use requires efforts from physicians, medical assistants, and office staff according to defined roles and responsibilities for data capture, review, and reporting.
Measuring and Monitoring Clinical Quality Measures in Practice FusionKimberly Hilton
Clinical Quality Measures (CQMs) are used to measure and monitor the quality of care provided in practices. CQMs consist of numerators and denominators that are defined by measure specifications. Practice Fusion supports recording CQM data elements to report on over 25 CQMs across all six National Quality Strategy domains. Providers can record screening results, assessments, and follow-up plans in the patient chart to submit CQM data for quality reporting programs.
The document outlines the 15 core requirements that must be met under Meaningful Use Stage 1, which include objectives like computerized provider order entry, drug interaction checks, maintaining problem lists and medication lists, recording vital signs and smoking status, implementing clinical decision support rules, and conducting security risk analyses to protect electronic health information. Eligible providers must meet thresholds for each objective through the use of certified electronic health records in order to qualify for financial incentives.
This document discusses pay-for-performance (P4P) programs, which provide financial incentives to healthcare providers for meeting quality benchmarks. The key points are:
1. P4P programs adjust payments to providers like physicians and hospitals based on performance measures related to quality, cost efficiency, and outcomes. Measures include structure, process, and outcomes.
2. The goals are to improve quality of care and reduce costs long-term by incentivizing evidence-based practices.
3. Providers are incentivized to improve quality through financial rewards or penalties based on meeting targets. However, programs have narrow focus and lack coordination between payers.
Ohio's Medicaid Managed Care program uses managed care organizations (MCOs) to provide services to over 1.5 million Medicaid enrollees. The program aims to improve access, quality, and consumer satisfaction. It establishes standards across domains like access, administrative capacity, and quality. MCOs are monitored based on performance measures and can face penalties for noncompliance. An external organization conducts annual reviews to evaluate MCOs and identify areas for quality improvement.
HTA training - Dr Roisin Adams - March 27th 2016ipposi
The NCPE conducts health technology assessments of pharmaceutical products for the HSE in Ireland. There are challenges to these assessments including small study sizes, uncertainty around long-term effects and costs, and a lack of head-to-head comparisons. Currently, the patient voice is heard both formally through quality-adjusted life year valuations that measure preferences for health, and informally through patient organizations and political debate. QALYs measure changes in length and quality of life on a unified scale. Ireland has valued health states hypothetically through methods like visual analog scales, ranking, and time trade-off exercises.
Meaningful Use encompasses multiple stages, each with specific timeline and measure requirements that continue to be a moving target. This can be a confusing process, sending providers in a tailspin in their attempts to stay current. This webinar focuses on the overall details of Meaningful Use and provides a nice outline of all of its details.
The document summarizes a presentation on examining the IBM report on the pan-Canadian Pharmaceutical Alliance (pCPA). The presentation includes an overview of the pCPA, a summary of the key findings and recommendations from the IBM report, and an update on the establishment of a pCPA secretariat as well as impacts on patient access.
The document provides information about the Academy of Managed Care Pharmacy (AMCP). It discusses:
1) AMCP was founded in 1989 and is a national professional society dedicated to promoting pharmaceutical care in managed healthcare environments.
2) AMCP's mission is to empower its over 5,700 members to improve healthcare for all individuals through the appropriate use of medications within managed care systems.
3) Key players in managed care include health plans, pharmacy benefit managers, the pharmaceutical industry, specialty pharmacy providers, retail pharmacies, and consulting firms. Pharmacists work in various roles across these organizations.
This document discusses pharmacoeconomics and its importance in balancing the interests of stakeholders in the healthcare industry. It begins by defining health economics and pharmacoeconomics, and explaining their relationship. It then discusses the shift in focus of healthcare consumers towards disease prevention. The document outlines various challenges faced by the healthcare industry and how pharmacoeconomic solutions can address the perspectives of patients, physicians, insurers, manufacturers, researchers and policymakers. It provides a case study on drug selection for osteoarthritis using pharmacoeconomic analysis. Finally, it discusses the global presence and potential for establishing pharmacoeconomics in India.
The document discusses key aspects of Meaningful Use Stage 1, including:
1) Eligible providers can qualify for EHR incentive payments through Medicare or Medicaid by meeting Meaningful Use objectives such as recording patient demographics and smoking status for a specified number of patients.
2) There are three stages of Meaningful Use with increasing requirements to improve outcomes, such as engaging patients and improving care coordination.
3) Providers have until February 28th of the following year to attest they met Meaningful Use requirements for an incentive payment for the prior year. Failure to meet requirements could result in penalties under Medicare.
This document provides an overview of pharmacoeconomics. It discusses the history and basics, including definitions of key terms like QALY. Methods of pharmacoeconomic evaluation are outlined, including cost-minimization analysis, cost-effectiveness analysis, cost-utility analysis, and cost-benefit analysis. Challenges in pharmacoeconomic evaluations are also summarized, such as the need for training and standardization of methods.
The Design of Accountable Care OrganizationsCJ Fulton
Pillars for Accountable Care
PCMH versus ACOs
Core competencies
Six core structural components of successful ACO deployment
Pioneer ACO burn and learn lessons
Barriers & root cause analysis
Patient attribution
Five modes of Accountable Care
Early value-based adopters
Value discovery assessment
Modified Triple Aim
GPRO
Breakdown by 33 Measures
This document provides a headcount timeline and projections for the GEM division of a company. It shows the current headcount, FY11 budget, projected quarterly headcounts, required hires, attrition rates, and monthly changes in headcount for the APJ, LA, and E-EMEA regions across three roles: Primary Quota Carriers, Solution Strategists, and Technical Sales. The headcount is projected to increase over the fiscal year to meet budgeted levels through new hires partially offset by attrition.
Results Matter: Blending Forman & Informal Learning for Employee Accreditationwillyerd1
The document discusses blending formal and informal learning for employee accreditation in sales roles. It proposes an accreditation process with four phases: knowledge, behavior, results, and contribution. For a sales representative role, the phases include passing a test on product knowledge, incorporating knowledge into an approved account plan, achieving sales goals, and contributing to informal learning communities. Metrics such as progress to quota and pipeline status will track the program's success. Next steps include integrating predictive analytics and completing the full accreditation implementation across other roles.
This is to show how reflection can be used as a performance management tool. Integrity has a reflective tool available to facilitate the use of reflection at work
This document summarizes changes from the proposed rule to the final rule for Stage 1 of the Medicare and Medicaid EHR Incentive Program's meaningful use criteria. Key changes included lowering thresholds for some objectives, removing administrative transactions, adding new objectives, and modifying clinical quality measures for eligible professionals. The final rule provided more flexibility for states and clarified various eligibility and reporting requirements.
This document summarizes changes from the proposed rule to the final rule for Stage 1 of the Medicare and Medicaid EHR Incentive Program's meaningful use criteria. Key changes included lowering thresholds for some objectives, removing administrative transactions, adding new objectives, and modifying clinical quality measures for eligible professionals. The final rule provided more flexibility for states and clarified various eligibility and reporting requirements.
This shows the structure of Integrity and the way the company operates. The products under development include interactive game style information to help small business owners get the employment stuff right
This document discusses issues at the intersection of technology and cyber law, including copyright, intellectual property, file sharing, privacy, and e-commerce. It explores core conflicts between current law and new digital technologies, challenges in regulating technologies that experience rapid growth and multiplication, and recent examples regarding copyright and privacy law. The document also looks ahead at emerging cyber law issues like spam and the legal aspects of e-commerce, as well as the potential regulation needed as technologies become more globalized.
This is a presentation for Her function in Wellington. It was designed to raise awareness of the issues around internet use at work, the use of social media at work and the Privacy Act
- The document discusses the requirements and incentives for physicians to achieve Meaningful Use of electronic health records as part of the government's stimulus program.
- Physicians must meet objectives in three stages involving electronic prescribing, clinical quality reporting, and advanced clinical processes to receive incentive payments of up to $44,000 from Medicare or $63,750 from Medi-Cal.
- Achieving Meaningful Use requires efforts from physicians, medical assistants, and office staff according to defined roles and responsibilities for data capture, review, and reporting.
Measuring and Monitoring Clinical Quality Measures in Practice FusionKimberly Hilton
Clinical Quality Measures (CQMs) are used to measure and monitor the quality of care provided in practices. CQMs consist of numerators and denominators that are defined by measure specifications. Practice Fusion supports recording CQM data elements to report on over 25 CQMs across all six National Quality Strategy domains. Providers can record screening results, assessments, and follow-up plans in the patient chart to submit CQM data for quality reporting programs.
The document outlines the 15 core requirements that must be met under Meaningful Use Stage 1, which include objectives like computerized provider order entry, drug interaction checks, maintaining problem lists and medication lists, recording vital signs and smoking status, implementing clinical decision support rules, and conducting security risk analyses to protect electronic health information. Eligible providers must meet thresholds for each objective through the use of certified electronic health records in order to qualify for financial incentives.
This document discusses pay-for-performance (P4P) programs, which provide financial incentives to healthcare providers for meeting quality benchmarks. The key points are:
1. P4P programs adjust payments to providers like physicians and hospitals based on performance measures related to quality, cost efficiency, and outcomes. Measures include structure, process, and outcomes.
2. The goals are to improve quality of care and reduce costs long-term by incentivizing evidence-based practices.
3. Providers are incentivized to improve quality through financial rewards or penalties based on meeting targets. However, programs have narrow focus and lack coordination between payers.
Ohio's Medicaid Managed Care program uses managed care organizations (MCOs) to provide services to over 1.5 million Medicaid enrollees. The program aims to improve access, quality, and consumer satisfaction. It establishes standards across domains like access, administrative capacity, and quality. MCOs are monitored based on performance measures and can face penalties for noncompliance. An external organization conducts annual reviews to evaluate MCOs and identify areas for quality improvement.
HTA training - Dr Roisin Adams - March 27th 2016ipposi
The NCPE conducts health technology assessments of pharmaceutical products for the HSE in Ireland. There are challenges to these assessments including small study sizes, uncertainty around long-term effects and costs, and a lack of head-to-head comparisons. Currently, the patient voice is heard both formally through quality-adjusted life year valuations that measure preferences for health, and informally through patient organizations and political debate. QALYs measure changes in length and quality of life on a unified scale. Ireland has valued health states hypothetically through methods like visual analog scales, ranking, and time trade-off exercises.
Meaningful Use encompasses multiple stages, each with specific timeline and measure requirements that continue to be a moving target. This can be a confusing process, sending providers in a tailspin in their attempts to stay current. This webinar focuses on the overall details of Meaningful Use and provides a nice outline of all of its details.
The document summarizes a presentation on examining the IBM report on the pan-Canadian Pharmaceutical Alliance (pCPA). The presentation includes an overview of the pCPA, a summary of the key findings and recommendations from the IBM report, and an update on the establishment of a pCPA secretariat as well as impacts on patient access.
The document provides information about the Academy of Managed Care Pharmacy (AMCP). It discusses:
1) AMCP was founded in 1989 and is a national professional society dedicated to promoting pharmaceutical care in managed healthcare environments.
2) AMCP's mission is to empower its over 5,700 members to improve healthcare for all individuals through the appropriate use of medications within managed care systems.
3) Key players in managed care include health plans, pharmacy benefit managers, the pharmaceutical industry, specialty pharmacy providers, retail pharmacies, and consulting firms. Pharmacists work in various roles across these organizations.
This document discusses pharmacoeconomics and its importance in balancing the interests of stakeholders in the healthcare industry. It begins by defining health economics and pharmacoeconomics, and explaining their relationship. It then discusses the shift in focus of healthcare consumers towards disease prevention. The document outlines various challenges faced by the healthcare industry and how pharmacoeconomic solutions can address the perspectives of patients, physicians, insurers, manufacturers, researchers and policymakers. It provides a case study on drug selection for osteoarthritis using pharmacoeconomic analysis. Finally, it discusses the global presence and potential for establishing pharmacoeconomics in India.
The document discusses key aspects of Meaningful Use Stage 1, including:
1) Eligible providers can qualify for EHR incentive payments through Medicare or Medicaid by meeting Meaningful Use objectives such as recording patient demographics and smoking status for a specified number of patients.
2) There are three stages of Meaningful Use with increasing requirements to improve outcomes, such as engaging patients and improving care coordination.
3) Providers have until February 28th of the following year to attest they met Meaningful Use requirements for an incentive payment for the prior year. Failure to meet requirements could result in penalties under Medicare.
This document provides an overview of pharmacoeconomics. It discusses the history and basics, including definitions of key terms like QALY. Methods of pharmacoeconomic evaluation are outlined, including cost-minimization analysis, cost-effectiveness analysis, cost-utility analysis, and cost-benefit analysis. Challenges in pharmacoeconomic evaluations are also summarized, such as the need for training and standardization of methods.
The Design of Accountable Care OrganizationsCJ Fulton
Pillars for Accountable Care
PCMH versus ACOs
Core competencies
Six core structural components of successful ACO deployment
Pioneer ACO burn and learn lessons
Barriers & root cause analysis
Patient attribution
Five modes of Accountable Care
Early value-based adopters
Value discovery assessment
Modified Triple Aim
GPRO
Breakdown by 33 Measures
This document provides a headcount timeline and projections for the GEM division of a company. It shows the current headcount, FY11 budget, projected quarterly headcounts, required hires, attrition rates, and monthly changes in headcount for the APJ, LA, and E-EMEA regions across three roles: Primary Quota Carriers, Solution Strategists, and Technical Sales. The headcount is projected to increase over the fiscal year to meet budgeted levels through new hires partially offset by attrition.
Results Matter: Blending Forman & Informal Learning for Employee Accreditationwillyerd1
The document discusses blending formal and informal learning for employee accreditation in sales roles. It proposes an accreditation process with four phases: knowledge, behavior, results, and contribution. For a sales representative role, the phases include passing a test on product knowledge, incorporating knowledge into an approved account plan, achieving sales goals, and contributing to informal learning communities. Metrics such as progress to quota and pipeline status will track the program's success. Next steps include integrating predictive analytics and completing the full accreditation implementation across other roles.
This is to show how reflection can be used as a performance management tool. Integrity has a reflective tool available to facilitate the use of reflection at work
This document summarizes changes from the proposed rule to the final rule for Stage 1 of the Medicare and Medicaid EHR Incentive Program's meaningful use criteria. Key changes included lowering thresholds for some objectives, removing administrative transactions, adding new objectives, and modifying clinical quality measures for eligible professionals. The final rule provided more flexibility for states and clarified various eligibility and reporting requirements.
This document summarizes changes from the proposed rule to the final rule for Stage 1 of the Medicare and Medicaid EHR Incentive Program's meaningful use criteria. Key changes included lowering thresholds for some objectives, removing administrative transactions, adding new objectives, and modifying clinical quality measures for eligible professionals. The final rule provided more flexibility for states and clarified various eligibility and reporting requirements.
This shows the structure of Integrity and the way the company operates. The products under development include interactive game style information to help small business owners get the employment stuff right
This document discusses issues at the intersection of technology and cyber law, including copyright, intellectual property, file sharing, privacy, and e-commerce. It explores core conflicts between current law and new digital technologies, challenges in regulating technologies that experience rapid growth and multiplication, and recent examples regarding copyright and privacy law. The document also looks ahead at emerging cyber law issues like spam and the legal aspects of e-commerce, as well as the potential regulation needed as technologies become more globalized.
This is a presentation for Her function in Wellington. It was designed to raise awareness of the issues around internet use at work, the use of social media at work and the Privacy Act
The document discusses fostering social learning communities in the workplace. It outlines why now is the time for social learning given trends in globalization, demographics, and social media use. It provides an overview of what social learning is and examples of social learning communities. The document then gives recommendations for what organizations should do prior to launching a social learning community, such as establishing readiness, guidelines, goals, and recruiting/training community managers. It also provides tips for launching, maintaining, and scaling social learning communities and measuring their impact.
Meaningful Use Workgroup Recommendations Brian Ahier
The document summarizes the recommendations of the Meaningful Use Workgroup to the HIT Policy Committee regarding the objectives for Stage 2 of Meaningful Use. The Workgroup aligned the objectives with national healthcare priorities and recommended raising thresholds or expanding criteria for many Stage 1 objectives. They also proposed maintaining the current timeline but allowing a 90-day reporting period for providers to address concerns about implementation feasibility.
This document summarizes the requirements for achieving meaningful use of electronic health records (EHRs) in order to qualify for incentive payments under the HITECH Act. It outlines the core and menu set objectives that must be met in each reporting period, including recording patient demographics, maintaining problem lists and medication lists, incorporating lab results into the EHR, exchanging health information electronically between providers, and reporting clinical quality measures to CMS or states. It also describes the services that regional extension centers like the North Carolina AHEC can provide to help practices select, implement, and optimize the use of certified EHR systems to meet meaningful use standards.
CoArtha Technolsolutions IT for Meaningful UseMapRecruit.com
CoArtha Technosolutions provides various healthcare IT services including electronic health record systems, healthcare portals, product development, and infrastructure management. The document discusses CoArtha's experience in healthcare domains, technologies used, and services offered to help healthcare providers achieve Meaningful Use of EHRs and qualify for related incentive payments under the HITECH Act.
The Physician Quality Reporting System (PQRS) provides incentives for eligible professionals who satisfactorily report data on quality measures for Medicare Part B patients. In 2011, eligible professionals can earn a 1% incentive by reporting on at least 3 measures. Starting in 2015, the PQRS program will use a value-based payment modifier to differentially pay physicians based on quality and cost performance measures. Alignment between PQRS and Meaningful Use is increasing, with many measures overlapping to reduce reporting burden. The future of PQRS includes expanding the number of measures and applying the value modifier to more physician groups over time.
What does ARRA, HITECH and Meaningful Use mean to youHealth 2.0
The document discusses the concepts of ARRA, HITECH, and Meaningful Use as they relate to adopting and using electronic health records (EHRs) in a meaningful manner. It provides an overview of the regulatory definitions and goals of Meaningful Use, as well as the three main regulations from CMS and ONC that specify requirements and standards. It also summarizes key aspects of the proposed EHR incentive programs for eligible professionals and hospitals, including eligibility, payment amounts and timelines, reporting requirements, and clinical quality measures.
The document discusses initiatives at Group Health Centre to improve patient care through health information technology innovations. It describes the implementation of an electronic medical record system (EMR XTRA) that allows pharmacists to access patient information, increasing collaboration between pharmacists and physicians. An evaluation found the program improved quality of care by identifying more drug-related problems and increasing medication management recommendations. The document also discusses preparing for electronic prescribing (ePrescribing) to further enhance coordination and safety of patient care.
OrHIMA Meaningful Use Stage 2 PresentationBrian Ahier
This document discusses changes from Stage 1 to Stage 2 of meaningful use for eligible professionals and hospitals. Key changes include increased objectives for clinical decision support, electronic prescribing, patient engagement and health information exchange. Stage 2 places more emphasis on care coordination through increased objectives for medication reconciliation, patient summaries and electronic transmission of health information between providers. The document also outlines new clinical quality reporting requirements and certification criteria for electronic health records.
The document provides information on the Medicare and Medicaid EHR incentive programs established under the HITECH Act to promote the meaningful use of electronic health records (EHRs) by eligible providers. It outlines the core and menu requirements to achieve meaningful use certification, associated incentive payment amounts for both programs from 2011-2021, and penalties for providers who do not successfully demonstrate meaningful use. The stages of meaningful use are also summarized, including the objectives and measures for Stage 1 which focus on data capture, tracking clinical conditions, and reporting clinical quality measures.
Keynote Presentation "Meaningful Use Stage 2 and Meaningful Use Audit Insight"
Think far beyond just threshold increases. The differences between Meaningful Use (MU) Stage 1 and Stage 2, including the 2014 Clinical Quality Measures, are technically and clinically challenging. And just when you thought you could safely look at Stage 1 in the rearview mirror, here come the audits! I will highlight the Stage 1 and Stage 2 differences and talk about the challenges they have initiated at Tenet. I will touch on the impact of Quality measures and will also provide you with insight into the basics of MU Audits and will take you through the actual audit experience at Tenet.
Learning Objectives:
∙ Review the program and measure changes from Stage 1 to Stage 2 and how the changes are being managed at Tenet
∙ Provide insight into the 2014 Clinical Quality Measures chosen by Tenet, the challenges posed, solutions that work and a little about the overall
impact of Quality measures
∙ Discuss Meaningful Use Audits, covering the basics as well as providing the benefit of the Tenet experience
This document provides an overview of the Medicare and Medicaid EHR Incentive Program for hospitals. It discusses who is eligible, how incentive payments are calculated, the meaningful use requirements including core and menu objectives, and clinical quality measures. Key details include that hospitals can receive incentives from both Medicare and Medicaid by meeting meaningful use through CMS, incentive payments are based on Medicaid and Medicare patient volumes and discharged and range from $2 million to multi-year payments, and Stage 1 meaningful use involves completing 14 core objectives and 5 out of 10 menu objectives.
Lawrence M. Preston provides a summary of the core and menu set measurements that medical practices must meet to qualify for incentive payments under Meaningful Use Phase I. There are 15 core criteria that must be met at 100% and practices must choose 5 out of 10 menu set criteria. The document outlines the specific requirements under each category and provides tips on implementation, such as getting help from vendors and focusing on physician buy-in. Weekly status reports are recommended to track progress.
Using Patient Registries and Automated Patient Outreach to Qualify for NCQA L...Phytel
The document discusses using patient registries and automated patient outreach to help medical practices qualify for level 3 recognition as a patient-centered medical home according to NCQA standards. It describes how the Phytel system can mine practice data to identify patients for recommended care, contact patients via automated outreach scripts, and generate reports on quality measures and financial results to document improved performance. Using these tools helped one practice profiled achieve the highest level of NCQA medical home qualification.
Connecting Patients, Providers and Payers John Halamka Keynotemihinpr
The document discusses goals and strategies for connecting patients, providers, and payers through healthcare IT and analytics. It outlines core objectives for physicians and hospitals that focus on clinical documentation, decision support, care coordination and exchange. It also describes various approaches to analytics using expert queries, self-service tools, repeatable reports and outsourced clinical repositories. The final sections discuss providing universal access to personal health records and required PHR functionality, as well as utilizing various decision support service providers.
The document provides an overview of meaningful use and the EHR incentive programs. It discusses the stages of meaningful use, eligibility requirements, incentive payment schedules, requirements for evidencing meaningful use such as objectives and measures, the EHR certification process, and next steps for providers in registering for incentive programs in 2011. The presentation was given by Scott Rogerson of consulting firm The Hill Group to prepare attendees for meaningful use.
The document summarizes the opportunity and need for healthcare providers to adopt electronic medical records (EMRs) to qualify for incentive payments under the HITECH Act. It outlines how adopting EMRs can help providers meet meaningful use standards and notes the large costs savings estimated from greater healthcare efficiencies and automation. It also highlights the growing requirements over the next few years that make it important for providers not to wait to implement an EMR system.
This document provides an overview of the Medicaid EHR Incentive Program's Stage 1 Meaningful Use requirements for 2016. It outlines 9 objectives and 2 public health measures that eligible providers must meet to qualify for incentive payments, including protecting health information, implementing clinical decision support, electronic prescribing, health information exchange, and public health reporting. It also describes exclusions, changes from prior years, and next steps providers should take to implement an EHR system and meet the objectives.
- Independent Living Systems (ILS) provides care transition management services using its Post-Acute Support System (PASS) program to help reduce hospital readmissions and healthcare costs.
- The PASS program coordinates patients' transition from hospitals to home through home visits, follow-up calls, and education on medication, nutrition, physician follow-ups and symptom monitoring.
- ILS works with health plans, hospitals, and provider organizations to implement PASS and achieve improved outcomes like lower readmission rates while providing cost savings.
1. Medicare & Medicaid EHR Incentive Program Final Rule Implementing the American Recovery & Reinvestment Act of 2009
2.
3.
4.
5.
6.
7.
8.
9.
10. Meaningful Use: Changes from the NPRM to the Final Rule NPRM Final Rule Meet all MU reporting objectives Must meet “core set”/can defer 5 from optional “menu set” 25 measures for EPs/23 measures for eligible hospitals 25 measures for EPs/24 for eligible hospitals Measure thresholds range from 10% to 80% of patients or orders (most at higher range) Measure thresholds range from 10% to 80% of patients or orders (most at lower to middle range) Denominators – To calculate the threshold, some measures required manual chart review Denominators – No measures require manual chart review to calculate threshold Administrative transactions (claims and eligibility) included Administrative transactions removed Measures for Patient-Specific Education Resources and Advanced Directives discussed but not proposed Measures for Patient-Specific Education Resources and Advanced Directives (for hospitals) included
11. Meaningful Use: Changes from the NPRM to the Final Rule, cont’d NPRM Final Rule States could propose requirements above/beyond MU floor, but not with additional EHR functionality States’ flexibility with Stage 1 MU is limited to seeking CMS approval to require 4 public health-related objectives to be core instead of menu Core clinical quality measures (CQM) and specialty measure groups for EPs Modified Core CQM and removed specialty measure groups for EPs 90 CQM total for EPs 44 CQM total for EPs – must report total of 6 35 CQM total for eligible hospitals and 8 alternate Medicaid CQM 15 CQM total for eligible hospitals 5 CQM overlap with CHIPRA initial core set 4 CQM overlap with CHIPRA initial core set
12.
13.
14.
15.
16. Meaningful Use – Stage 1 Core Set Health Outcomes Policy Priority Stage 1 Objective Stage 1 Measure Improving quality, safety, efficiency, and reducing health disparities Use CPOE for medication orders directly entered by any licensed healthcare professional who can enter orders into the medical record per state, local, and professional guidelines More than 30% of unique patients with at least one medication in their medication list seen by the EP or admitted to the eligible hospital or CAH have at least one medication entered using CPOE Implement drug-drug and drug-allergy interaction checks The EP/eligible hospital/CAH has enabled this functionality for the entire EHR reporting period EP Only: Generate and transmit permissible prescriptions electronically (eRx) More than 40% of all permissible prescriptions written by the EP are transmitted electronically using certified EHR technology Record demographics: preferred language, gender, race, ethnicity, date of birth, and date and preliminary cause of death in the event of mortality in the eligible hospital or CAH More than 50% of all unique patients seen by the EP or admitted to the eligible hospital or CAH have demographics as recorded structured data Maintain up-to-date problem list of current and active diagnoses More than 80% of all unique patients seen by the EP or admitted to the eligible hospital or CAH have at least one entry or an indication that no problems are known for the patient recorded as structured data
17. Meaningful Use – Stage 1 Core Set, cont’d Health Outcomes Policy Priority Stage 1 Objective Stage 1 Measure Improving quality, safety, efficiency, and reducing health disparities Maintain active medication list More than 80% of all unique patents seen by the EP or admitted to the eligible hospital or CAH have at least one entry (or an indication that the patient is not currently prescribed any medication) recorded as structured data Maintain active medication allergy list More than 80% of all unique patents seen by the EP or admitted to the eligible hospital or CAH have at least one entry (or an indication that the patient has no known medication allergies) recorded as structured data Record and chart vital signs: height, weight, blood pressure, calculate and display BMI, plot and display growth charts for children 2-20 years, including BMI For more than 50% of all unique patients age 2 and over seen by the EP or admitted to the eligible hospital or CAH, height, weight, and blood pressure are recorded as structured data Record smoking status for patients 13 years old or older More than 50% of all unique patients 13 years or older seen by the EP or admitted to the eligible hospital or CAH have smoking status recorded as structured data Implement one clinical decision support rule and the ability to track compliance with the rule Implement one clinical decision support rule Report clinical quality measures to CMS or the States For 2011, provide aggregate numerator, denominator, and exclusions through attestation; For 2012, electronically submit clinical quality measures
18. Meaningful Use – Stage 1 Core Set, cont’d Health Outcomes Policy Priority Stage 1 Objective Stage 1 Measure Engage patients and families in their healthcare Provide patients with an electronic copy of their health information (including diagnostic test results, problem list, medication lists, medication allergies, discharge summary, procedures), upon request More than 50% of all unique patients of the EP, eligible hospital or CAH who request an electronic copy of their health information are provided it within 3 business days Hospitals Only: Provide patients with an electronic copy of their discharge instructions at time of discharge, upon request More than 50% of all patients who are discharged from an eligible hospital or CAH who request an electronic copy of their discharge instructions are provided it EPs Only: Provide clinical summaries for each office visit Clinical summaries provided to patients for more than 50% of all office visits within 3 business days Improve care coordination Capability to exchange key clinical information (ex: problem list, medication list, medication allergies, diagnostic test results), among providers of care and patient authorized entities electronically Performed at least one test of the certified EHR technology’s capacity to electronically exchange key clinical information Ensure adequate privacy and security protections for personal health information Protect electronic health information created or maintained by certified EHR technology through the implementation of appropriate technical capabilities Conduct or review a security risk analysis per 45 CFR 164.308(a)(1) and implement updates as necessary and correct identified security deficiencies as part of the EP’s, eligible hospital’s or CAH’s risk management process
19. Meaningful Use – Stage 1 Menu Set Health Outcomes Policy Priority Stage 1 Objective Stage 1 Measure Improving quality, safety, efficiency, and reducing health disparities Implement drug-formulary checks The EP/eligible hospital/CAH has enabled this functionality and has access to at least one internal or external drug formulary for the entire EHR reporting period Hospitals Only: Record advance directives for patients 65 years old or older More than 50% of all unique patients 65 years old or older admitted to the eligible hospital or CAH have an indication of an advance directive status recorded Incorporate clinical lab-test results into certified EHR technology as structured data More than 40% of all clinical lab test results ordered by the EP, or an authorized provider of the eligible hospital or CAH, for patients admitted during the EHR reporting period whose results are either in a positive/negative or numerical format are incorporated in certified EHR technology as structured data Generate lists of patients by specific conditions to use for quality improvement, reduction of disparities, research or outreach Generate at least one report listing patients of the EP, eligible hospital or CAH with a specific condition EPs Only: Send reminders to patients per patient preference for preventive/follow-up care More than 20% of all unique patients 65 years or older or 5 years old or younger were sent an appropriate reminder during the EHR reporting period
20. Meaningful Use – Stage 1 Menu Set, cont’d Health Outcomes Policy Priority Stage 1 Objective Stage 1 Measure Engage patients and families in their health care EPs Only: Provide patients with timely electronic access to their health information (including lab results, problem list, medication lists, medication allergies) within 4 business days of the information being available to the EP More than 10% of all unique patients seen by the EP are provided timely (available to the patient within 4 business days of being updated in the certified EHR technology) electronic access to their health information subject to the EP’s discretion to withhold certain information Use certified EHR technology to identify patient-specific education resources and provide those resources to the patient, if appropriate More than 10% of all unique patients seen by the EP or admitted to the eligible hospital or CAH are provided patient-specific education resources Improve care coordination The EP, eligible hospital or CAH who receives a patient from another setting of care or provider of care or believes an encounter is relevant should perform medication reconciliation The EP, eligible hospital or CAH performs medication reconciliation for more than 50% of transitions of care in which the patient is transitioned into the care of the EP or admitted to the eligible hospital or CAH The EP, eligible hospital or CAH who receives a patient from another setting of care or provider of care or refers their patient to another provider of care should provide a summary of care record for each transition of care or referral The EP, eligible hospital or CAH who transitions or refers their patient to another setting of care or provider of care provides a summary of care record for more than 50% of transitions of care and referrals
21. Meaningful Use – Stage 1 Menu Set, cont’d 1 Unless an EP, eligible hospital or CAH has an exception for all of these objectives and measures they must complete at least one as part of their demonstration of the menu set in order to be a meaningful EHR user. Health Outcomes Policy Priority Stage 1 Objective Stage 1 Measure Improve population and public health 1 Capability to submit electronic data to immunization registries or Immunization Information Systems and actual submission in accordance with applicable law and practice Performed at least one test of the certified EHR technology’s capacity to submit electronic data to immunization registries and follow-up submission if the test is successful (unless none of the immunization registries to which the EP, eligible hospital or CAH submits such information have the capacity to receive such information electronically) Hospitals Only: Capability to submit electronic data on reportable (as required by state or local law) lab results to public health agencies and actual submission in accordance with applicable law and practice Performed at least one test of certified EHR technology’s capacity to provide submission of reportable lab results to public health agencies and follow-up submission if the test is successful (unless none of the public health agencies to which the EP, eligible hospital or CAH submits such information have the capacity to receive such information electronically) Capability to submit electronic syndromic surveillance data to public health agencies and actual submission in accordance with applicable law and practice Performed at least one test of certified EHR technology’s capacity to provide electronic syndromic surveillance data to public health agencies and follow-up submission if the test is successful (unless none of the public health agencies to which the EP, eligible hospital or CAH submits such information have the capacity to receive such information electronically)
22.
23.
24.
25.
26.
27.
28. CQM: Core Set for EPs NQF Measure Number & PQRI Implementation Number Clinical Quality Measure Title NQF 0013 Hypertension: Blood Pressure Measurement NQF 0028 Preventive Care and Screening Measure Pair: a) Tobacco Use Assessment b) Tobacco Cessation Intervention NQF 0421 PQRI 128 Adult Weight Screening and Follow-up
29. CQM: Alternate Core Set for EPs NQF Measure Number & PQRI Implementation Number Clinical Quality Measure Title NQF 0024 Weight Assessment and Counseling for Children and Adolescents NQF 0041 PQRI 110 Preventive Care and Screening: Influenza Immunization for Patients 50 Years Old or Older NQF 0038 Childhood Immunization Status
30.
31.
32.
33. Participation in HITECH and other Medicare Incentive Programs for EPs Other Medicare Incentive Program Eligible for HITECH EHR Incentive Program? Medicare Physician Quality Reporting Initiative (PQRI) Yes, if the EP is eligible. Medicare Electronic Health Record Demonstration (EHR Demo) Yes, if the EP is eligible. Medicare Care Management Performance Demonstration (MCMP) Yes, if the practice is eligible. The MCMP demo will end before EHR incentive payments are available. Electronic Prescribing (eRx) Incentive Program If the EP chooses to practice in the Medicare EHR Incentive Program, they cannot participate in the Medicare eRx Incentive Program simultaneously in the same program year. If the EP chooses to participate in the Medicaid EHR Incentive Program, they can participate in the Medicare eRx Incentive Program simultaneously.
34.
35.
Editor's Notes
Logo: EHR Incentive Programs (Tagline: Connecting America for Better Health) Logo: CMS – Centers for Medicare and Medicaid Services
NPRM vs. Final Rule Meet all MU reporting objectives vs. Must meet “core set”/can defer 5 from optional “menu set” 25 measures for EPs/23 for eligible hospitals vs. 25 measures for EPs/24 for eligible hospitals Measure thresholds range from 10% to 80% of patients or orders (most at higher range) vs. Measure thresholds range from 10% to 80% of patients or orders (most at lower to middle range) Denominators – To calculate the threshold, some measures required manual chart review vs. Denominators – No measures require manual chart review to calculate threshold (Speaker Note: Manual chart review including the counting of orders. For the final rule, the only counting that would be required would be to know the number of patients seen or admitted during the EHR reporting period. All other denominators can be obtained automatically using certified EHR technology. ) Administrative transactions (claims and eligibility) included vs. Administrative transactions removed Measures for Patient-Specific Education Resources and Advanced Directives discussed but not proposed vs. Measures for Patient-Specific Education Resources and Advanced Directives (for hospitals) included
NPRM vs. Final Rule, continued States could propose above/beyond MU floor, but not with additional EHR functionality vs. States’ flexibility with Stage 1 MU is limited to seeking CMS approval to require 4 public health-related objectives to be core instead of menu Core CQM and specialty measure groups for EPs vs. Modified Core CQM and removed specialty measure groups for EPs 90 CQM total for EPs vs. 44 CQM total for EPs – must report total of 6 35 CQM total for eligible hospitals and 8 alternate Medicaid CQM vs. 15 CQM total for eligible hospitals 5 CQM overlap with CHIPRA initial core set vs. 4 CQM overlap with CHIPRA initial core set
Core Set CQM for EPs Hypertension: Blood Pressure Measurement (NQF 0013) Preventive Care and Screening Measure Pair: a) Tobacco Use Assessment b) Tobacco Cessation Intervention (NQF 0028) Adult Weight Screening and Follow-up (NQF 0421, PQRI 128)
Alternate Core CQM Set for EPs Weight Assessment and Counseling for Children and Adolescents (NQF 0024) Preventive Care and Screening: Influenza Immunization for Patients > 50 Years old (NQF 0041, PQRI 110) Childhood Immunization Status (NQF 0038)
Other Medicare Incentive Program -- Eligible for HITECH? Medicare Physician Quality Reporting Initiative (PQRI) -- Yes, if the EP is eligible. Medicare Electronic Health Records Demonstration (EHR Demo) -- Yes, if the EP is eligible. Medicare Care Management Performance Demonstration (MCMP) -- Yes, if the practice is eligible. The MCMP demo will end before EHR incentive payments are available. Electronic Prescribing (eRx) Incentive Program -- If the EP chooses to practice in the Medicare EHR Incentive Program, they cannot participate in the Medicare eRx Incentive Program simultaneously in the same program year. If the EP chooses to participate in the Medicaid EHR Incentive Program, they can participate in the Medicare eRx Incentive Program simultaneously.